SlideShare a Scribd company logo
Introduction to Biostatistics and
Epidemiology
Vashini Pillay
vash.pillay@uct.ac.za
Philosophical background
• Basic premise: there is an external, objective
“truth” that applies to the whole population
• We will never know the Truth
• We can estimate the Truth by testing a sample
of the population
• Make some inferences about the whole
population
• Question:
– How well does this estimate represent the Truth?
3 Questions
1) Is the sample data representative of the
population (ie free of bias)
– Can’t answer this question with statistical methods
– Need to examine how the data was collected
2) “Is there an association”
– Look at point estimate (RR / OR / RRR / ARR / NNT)
3) How likely is it that this result occurred by
chance?
– P values and confidence intervals may help
1. Bias
• A systematic error in the design, conduct
or analysis of the study which results in a
mistaken estimate of the exposure-
outcome relationship.
• It is NOT due to random variability
(ie:chance).
1. Bias
• Selection Bias:
-systematic errors in the selection of subjects
(the manner in which subjects are selected into the study leads to
systematic differences in the distributions of these subjects in the
exposure/outcome groups compared to the original source
population)
• Information Bias:
-systematic errors in the collection of information
from study subjects
(some of the information collected with regards to either the exposure
or the outcome is incorrect resulting in study subjects being
misclassified into the incorrect study group)
Anna Grimsrud March 2009
1. Bias
• Types of Selection Bias:
- prevalence bias
- participation bias
- sampling bias
-LTFU
• Types of Information Bias:
- recall bias
- measurement bias
- observer bias
- assessment bias
Anna Grimsrud March 2009
Study Designs
• Observational Studies:
- Case Study
- Case Series
- Cross-sectional
- Cohort
- Case Control
• Experimental Studies:
- Randomized Controlled Trials
Study Designs
• Influence the way in which we sample
study population
• Influence the way in which we measure /
collect data
• Influence the manner in which we analyse
data
2. Is there an Association?
• Risk Ratio
the ratio of the risk of developing the outcome of
interest (eg:disease) in the exposed subjects to
the risk of developing the outcome of interest in
the non-exposed subjects.
RR > 1 : Risk of disease is greater among the exposed than
among the non-exposed
RR = 1: Risk of disease is the same among the exposed and
the non-exposed
RR < 1: Risk of disease is less among the exposed than
among the non-exposed (ie: protective effect)
2. Is there an Association?
• Odds Ratio
the ratio of the odds of developing the outcome of
interest (eg:disease) in the exposed subjects to
the odds of developing the outcome of interest in
the non-exposed subjects.
OR > 1 : Odds of disease is greater among the exposed than
among the non-exposed
OR = 1: Odds of disease is the same among the exposed and
the non-exposed
OR < 1: Odds of disease is less among the exposed than
among the non-exposed (ie: protective effect)
2. Is the Association real ?
– To “detect an association” that isn’t real = type 1 error
(False Positive in Diagnostic Testing)
– To “miss an association” that is actually there = type 2
error
(False Negative in Diagnostic Testing)
• This decision should be reviewed and quantified
on every analysis
3. How likely is it that this result
occurred by chance?
• P-values deal with probability of the
estimate
• Confidence Intervals also deal with the
precision of the estimate
Null Hypothesis
• The Null Hypothesis traditionally states
that there is no difference in association /
relationship between 2 measured
phenomena (default / reference point)
• Alternative Hypothesis states that there
is a difference in association / relationship
between 2 measured phenomena.
P-Value
• “The probability of obtaining a result as extreme
as this, assuming the Null Hypothesis is true”
• A measure to quantify your degree of certainty
with regards to the result obtained
(ie: the estimate of the probability that the result obtained has
occurred by pure statistical chance/accident).
• The smaller the p-value, the more likely you are
to reject the Null (ie: the observed association is
very unlikely to have occurred by chance alone)
P-Value
• P-value = 0.5 means that the probability of the result
obtained having happened by chance is 1 in 2.
• P-value =0.05 means that the probability of the result
obtained having happened by chance is 1 in 20.
• P-value = 0.01 means that the probability of the result
obtained having happened by chance is 1 in 100.
• P-value = 0.001 means that the probability of the result
obtained having happened by chance is 1 in 1000
P-Value
• Traditionally a p-value < 0.05 or less
rejects the Null Hypothesis at the 5%
significance level suggesting statistical
significance.
BUT… in terms of clinical significance:
• Is a p-value of 0.049 very different from
that of 0.05???
• Is a p-value of 0.051 very different from
that of 0.05???
Problems with P-values
• Statisticians hate them (for many complex reasons)
– Major abuse of p value:
• Label variable S or NS (significant or not significant)
-based on a single threshold value
-without looking at the magnitude of the effect
-without looking at the clinical significance of the effect
– Eg a cancer etiology study shows
• Suggestive evidence of an enormous increase in risk with chemical A
– Risk ratio 13.4, p=0.051
• Strong evidence of a small increase in risk with chemical B
– Risk ratio 1.10, p=0.001
– Chemical A: 13 times increased risk
– Chemical B: 10% increased risk
Never mind the p value, which chemical are you more afraid of?
Common misconceptions of P-Values
• P = 0.05 does not mean there is only a 5% chance that
the null hypothesis is true.
• P = 0.05 does not mean there is a 5% chance of a Type I
error (i.e. false positive).
• P = 0.05 does not mean there is a 95% chance that the
results would replicate if the study were repeated.
• P > 0.05 does not mean there is no difference between
groups.
• P < 0.05 does not mean you have proved your
experimental hypothesis.
Goodman S.A. Ann Intern Med. 1999;130:995-1004
Confidence interval
• Emphasis on precision of the estimate
- provides a range of values in which the estimate
obtained through ones analysis, would be considered
precise.
• Derived from same underlying parameters (variance and
sample size)
• Provides us with more information than a p-value
Normal distribution
• For a normally shaped distribution, 1
standard deviation on either side of the
mean contains 66% of the estimates
• 2 standard deviations contain on either
side of the mean contains 97% of the
estimates
• 1.96 standard deviations contain 95% of
the estimates
Sampling distribution showing effect of sampling error (SE).
Sheldon T A Evid Based Nurs 2000;3:36-39
©2000 by BMJ Publishing Group Ltd and RCN Publishing Company Ltd
Calculate 95% confidence interval
• Calculate sample statistic (point estimate)
• Calculate “standard error” (SE) of the statistic
– “Standard error” is similar to standard deviation
(ie: standard deviation of the sample population)
– Measure of the “spread” of the data
– Affected by sample size
• Calculate 1.96 x SE
• Upper limit: Point estimate + 1.96xSE
• Lower limit: Point estimate -1.96xSE
Sample size
• Larger sample size – smaller standard
error – narrower confidence intervals
• Greater precision
• If the upper limit and lower limit include /
cross the value 1, then the result is not
statistically significant (at 5% level)
The larger the sample (n), the smaller the sampling error.
Sheldon T A Evid Based Nurs 2000;3:36-39
©2000 by BMJ Publishing Group Ltd and RCN Publishing Company Ltd
Reporting a confidence interval
• “The truth” existed before you took your sample, it is
what it is, and it is unchanging
• Your estimates may be variable (depending on how you
took the sample, how many times you repeat the test)
• The truth is fixed, your estimates are flexible
• “We can say with 95% confidence that this interval
includes/covers/overlaps the Truth”
• You cannot say: “The truth falls within this interval”
– Implies that your borders are fixed, and the truth is variable, may
“fall” here or “fall” there
– The truth is fixed! Your intervals are variable
Advantage of confidence intervals
• Can see size of effect
• Width of confidence interval gives idea of
the “stability” of the estimate
– Sample size?
– Effect of some extreme outlier values?
– Random error?
• Narrow CI’s are always better!
P Value vs CI
• Hypothetical disease:
• Which exposures are
statistically significant? (p
values)
• Which has widest CI?
(most affected by random
error)
• Which are most precise
(most trustworthy, less
likely to change with
repeat testing)?
Exposure Relative
risk
95% CI P
value
A 2.1 0.6 – 7.8 0.24
B 1.6 1.3 – 2.0 0.001
C 4.4 1.5 – 12.4 0.002
Past paper examples: Mar 2008
• You are interested in interventions that could be used in the area that could prevent
relapse after discharge in children with severe malnutrition treated at the hospital.
You find the following article during an evidence-base search
• “Home based therapy for severe malnutrition with ready-to-use food “
– M J Manary, M J Ndkeha, P Ashorn, K Maleta, A Briend
• Background:
– The standard treatment of severe malnutrition in Malawi often utilises prolonged inpatient
care, and after discharge results in high rates of relapse.
• Aims:
– To test the hypothesis that the recovery rate, defined as catch-up growth such that weight-
for-height z score >0 (WHZ, based on initial height) for ready-to-use food (RTUF) is greater
than two other home based dietary regimens in the treatment of malnutrition.
• Methods:
– HIV negative children >1 year old discharged from the nutrition unit in Blantyre, Malawi were
randomised to one of three dietary regimens: RTUF, RTUF supplement, or blended
maize/soy flour. RTUF and maize/soy flour provided 730 kJ/kg/day, while the RTUF
supplement provided a fixed amount of energy, 2100 kJ/day.
– Children were followed fortnightly. Children completed the study when they reached WHZ
>0, relapsed, or died.
– Outcomes were compared using a time-event model.
• Results:
– A total of 282 children were enrolled.
– Children receiving RTUF were more likely to reach WHZ >0 than those
receiving RTUF supplement or maize/soy flour (95% v 78%, RR 1.2,
95% CI 1.1 to 1.3).
– Intention to treat analyses also showed that more children receiving
RTUF reached graduation weight than those receiving RTUF
supplement or maize/soy (86% v 66%, 20% difference, 95% CI 8% to
33%).
– The average weight gain was 5.2 g/kg/day in the RTUF group compared
to 3.1 g/kg/day for the maize/soy and RTUF supplement groups. Six
months later, 96% of all children who reached graduation weight and
returned for follow up, had normal anthropometric indices
• Abbreviations:
– MUAC, mid-upper arm circumference; NRU, nutritional rehabilitation
unit; RTUF, ready-to-use food; WHZ, weight-for-height z score
• a) What type of study design was used? (1)
• b) What was the main study outcome? (1)
• c) How would you interpret a weight-for-height z-score of 0 and -1? (2)
• d) How would you interpret the relative risk of 1.2 in the statement
“Children receiving RTUF were more likely to reach WHZ >0 than those
receiving RTUF supplement or maize/soy flour (95% v 78%, RR 1.2, 95%
CI 1.1 to 1.3).”? (1)
• e) How would you interpret the 95% confidence interval of 1.1 to 1.3 in
the same sentence? (1)
• f) Was this difference statistically significant? Explain. (1)
• g) What statistical test would you use to decide if the average weight
gain in the RTUF group was significantly different to the maize/soy and
RTUF supplement groups? (1)
• h) What would your conclusion be about managing children with severe
malnutrition at home, based on this Study? (3)
Sept 2010:
Biostatistics and epidemiology 01stats20
Sept 2008: ex prem, spastic di
Biostatistics and epidemiology 01stats20
Biostatistics and epidemiology 01stats20

More Related Content

PPTX
Module7_RamdomError.pptx
PDF
Lecture by Professor Imre Janszky about random error.
PPT
Lecture2 hypothesis testing
PPT
COM 301 INFERENTIAL STATISTICS SLIDES.ppt
PPT
Introductory Statistics
PPTX
Epidemiology Chapter 5.pptx
PPTX
Overview of different statistical tests used in epidemiological
PDF
introduction to biostatistics in clinical trials
Module7_RamdomError.pptx
Lecture by Professor Imre Janszky about random error.
Lecture2 hypothesis testing
COM 301 INFERENTIAL STATISTICS SLIDES.ppt
Introductory Statistics
Epidemiology Chapter 5.pptx
Overview of different statistical tests used in epidemiological
introduction to biostatistics in clinical trials

Similar to Biostatistics and epidemiology 01stats20 (20)

PDF
introduction to biostatistics in clinical trials
PPTX
How to do the maths
PPT
Statistics basics for oncologist kiran
PPTX
Biostatistics.pptx
PPT
Copenhagen 23.10.2008
PPT
How to read a paper
PPTX
Common measures and statistics in epidemiological literature
PPT
Copenhagen 2008
PPTX
Bio-Statistics in Bio-Medical research
PDF
Common Statistical Concerns in Clinical Trials
PPT
Biostatistics
PPTX
Epidemiological statistics
PPT
Statistics tests and Probablity
PDF
3b. Introductory Statistics - Julia Saperia
PPTX
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
PPTX
Application of statistical tests in Biomedical Research .pptx
PPTX
PDF
Statistics for Lab Scientists
PPTX
introduction to biostatistics in clinical trials
How to do the maths
Statistics basics for oncologist kiran
Biostatistics.pptx
Copenhagen 23.10.2008
How to read a paper
Common measures and statistics in epidemiological literature
Copenhagen 2008
Bio-Statistics in Bio-Medical research
Common Statistical Concerns in Clinical Trials
Biostatistics
Epidemiological statistics
Statistics tests and Probablity
3b. Introductory Statistics - Julia Saperia
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Application of statistical tests in Biomedical Research .pptx
Statistics for Lab Scientists
Ad

Recently uploaded (20)

PDF
How to run a consulting project- client discovery
PPTX
AI Strategy room jwfjksfksfjsjsjsjsjfsjfsj
PDF
Introduction to the R Programming Language
PPTX
Leprosy and NLEP programme community medicine
PDF
Optimise Shopper Experiences with a Strong Data Estate.pdf
PDF
REAL ILLUMINATI AGENT IN KAMPALA UGANDA CALL ON+256765750853/0705037305
PPTX
Managing Community Partner Relationships
PDF
Capcut Pro Crack For PC Latest Version {Fully Unlocked 2025}
PPTX
01_intro xxxxxxxxxxfffffffffffaaaaaaaaaaafg
PPTX
QUANTUM_COMPUTING_AND_ITS_POTENTIAL_APPLICATIONS[2].pptx
PPTX
(Ali Hamza) Roll No: (F24-BSCS-1103).pptx
PPTX
Acceptance and paychological effects of mandatory extra coach I classes.pptx
PDF
Systems Analysis and Design, 12th Edition by Scott Tilley Test Bank.pdf
PPTX
A Complete Guide to Streamlining Business Processes
PDF
Microsoft Core Cloud Services powerpoint
PDF
Data Engineering Interview Questions & Answers Batch Processing (Spark, Hadoo...
PPTX
modul_python (1).pptx for professional and student
PDF
Transcultural that can help you someday.
PPTX
Introduction to Inferential Statistics.pptx
PPTX
retention in jsjsksksksnbsndjddjdnFPD.pptx
How to run a consulting project- client discovery
AI Strategy room jwfjksfksfjsjsjsjsjfsjfsj
Introduction to the R Programming Language
Leprosy and NLEP programme community medicine
Optimise Shopper Experiences with a Strong Data Estate.pdf
REAL ILLUMINATI AGENT IN KAMPALA UGANDA CALL ON+256765750853/0705037305
Managing Community Partner Relationships
Capcut Pro Crack For PC Latest Version {Fully Unlocked 2025}
01_intro xxxxxxxxxxfffffffffffaaaaaaaaaaafg
QUANTUM_COMPUTING_AND_ITS_POTENTIAL_APPLICATIONS[2].pptx
(Ali Hamza) Roll No: (F24-BSCS-1103).pptx
Acceptance and paychological effects of mandatory extra coach I classes.pptx
Systems Analysis and Design, 12th Edition by Scott Tilley Test Bank.pdf
A Complete Guide to Streamlining Business Processes
Microsoft Core Cloud Services powerpoint
Data Engineering Interview Questions & Answers Batch Processing (Spark, Hadoo...
modul_python (1).pptx for professional and student
Transcultural that can help you someday.
Introduction to Inferential Statistics.pptx
retention in jsjsksksksnbsndjddjdnFPD.pptx
Ad

Biostatistics and epidemiology 01stats20

  • 1. Introduction to Biostatistics and Epidemiology Vashini Pillay vash.pillay@uct.ac.za
  • 2. Philosophical background • Basic premise: there is an external, objective “truth” that applies to the whole population • We will never know the Truth • We can estimate the Truth by testing a sample of the population • Make some inferences about the whole population • Question: – How well does this estimate represent the Truth?
  • 3. 3 Questions 1) Is the sample data representative of the population (ie free of bias) – Can’t answer this question with statistical methods – Need to examine how the data was collected 2) “Is there an association” – Look at point estimate (RR / OR / RRR / ARR / NNT) 3) How likely is it that this result occurred by chance? – P values and confidence intervals may help
  • 4. 1. Bias • A systematic error in the design, conduct or analysis of the study which results in a mistaken estimate of the exposure- outcome relationship. • It is NOT due to random variability (ie:chance).
  • 5. 1. Bias • Selection Bias: -systematic errors in the selection of subjects (the manner in which subjects are selected into the study leads to systematic differences in the distributions of these subjects in the exposure/outcome groups compared to the original source population) • Information Bias: -systematic errors in the collection of information from study subjects (some of the information collected with regards to either the exposure or the outcome is incorrect resulting in study subjects being misclassified into the incorrect study group) Anna Grimsrud March 2009
  • 6. 1. Bias • Types of Selection Bias: - prevalence bias - participation bias - sampling bias -LTFU • Types of Information Bias: - recall bias - measurement bias - observer bias - assessment bias Anna Grimsrud March 2009
  • 7. Study Designs • Observational Studies: - Case Study - Case Series - Cross-sectional - Cohort - Case Control • Experimental Studies: - Randomized Controlled Trials
  • 8. Study Designs • Influence the way in which we sample study population • Influence the way in which we measure / collect data • Influence the manner in which we analyse data
  • 9. 2. Is there an Association? • Risk Ratio the ratio of the risk of developing the outcome of interest (eg:disease) in the exposed subjects to the risk of developing the outcome of interest in the non-exposed subjects. RR > 1 : Risk of disease is greater among the exposed than among the non-exposed RR = 1: Risk of disease is the same among the exposed and the non-exposed RR < 1: Risk of disease is less among the exposed than among the non-exposed (ie: protective effect)
  • 10. 2. Is there an Association? • Odds Ratio the ratio of the odds of developing the outcome of interest (eg:disease) in the exposed subjects to the odds of developing the outcome of interest in the non-exposed subjects. OR > 1 : Odds of disease is greater among the exposed than among the non-exposed OR = 1: Odds of disease is the same among the exposed and the non-exposed OR < 1: Odds of disease is less among the exposed than among the non-exposed (ie: protective effect)
  • 11. 2. Is the Association real ? – To “detect an association” that isn’t real = type 1 error (False Positive in Diagnostic Testing) – To “miss an association” that is actually there = type 2 error (False Negative in Diagnostic Testing) • This decision should be reviewed and quantified on every analysis
  • 12. 3. How likely is it that this result occurred by chance? • P-values deal with probability of the estimate • Confidence Intervals also deal with the precision of the estimate
  • 13. Null Hypothesis • The Null Hypothesis traditionally states that there is no difference in association / relationship between 2 measured phenomena (default / reference point) • Alternative Hypothesis states that there is a difference in association / relationship between 2 measured phenomena.
  • 14. P-Value • “The probability of obtaining a result as extreme as this, assuming the Null Hypothesis is true” • A measure to quantify your degree of certainty with regards to the result obtained (ie: the estimate of the probability that the result obtained has occurred by pure statistical chance/accident). • The smaller the p-value, the more likely you are to reject the Null (ie: the observed association is very unlikely to have occurred by chance alone)
  • 15. P-Value • P-value = 0.5 means that the probability of the result obtained having happened by chance is 1 in 2. • P-value =0.05 means that the probability of the result obtained having happened by chance is 1 in 20. • P-value = 0.01 means that the probability of the result obtained having happened by chance is 1 in 100. • P-value = 0.001 means that the probability of the result obtained having happened by chance is 1 in 1000
  • 16. P-Value • Traditionally a p-value < 0.05 or less rejects the Null Hypothesis at the 5% significance level suggesting statistical significance. BUT… in terms of clinical significance: • Is a p-value of 0.049 very different from that of 0.05??? • Is a p-value of 0.051 very different from that of 0.05???
  • 17. Problems with P-values • Statisticians hate them (for many complex reasons) – Major abuse of p value: • Label variable S or NS (significant or not significant) -based on a single threshold value -without looking at the magnitude of the effect -without looking at the clinical significance of the effect – Eg a cancer etiology study shows • Suggestive evidence of an enormous increase in risk with chemical A – Risk ratio 13.4, p=0.051 • Strong evidence of a small increase in risk with chemical B – Risk ratio 1.10, p=0.001 – Chemical A: 13 times increased risk – Chemical B: 10% increased risk Never mind the p value, which chemical are you more afraid of?
  • 18. Common misconceptions of P-Values • P = 0.05 does not mean there is only a 5% chance that the null hypothesis is true. • P = 0.05 does not mean there is a 5% chance of a Type I error (i.e. false positive). • P = 0.05 does not mean there is a 95% chance that the results would replicate if the study were repeated. • P > 0.05 does not mean there is no difference between groups. • P < 0.05 does not mean you have proved your experimental hypothesis. Goodman S.A. Ann Intern Med. 1999;130:995-1004
  • 19. Confidence interval • Emphasis on precision of the estimate - provides a range of values in which the estimate obtained through ones analysis, would be considered precise. • Derived from same underlying parameters (variance and sample size) • Provides us with more information than a p-value
  • 20. Normal distribution • For a normally shaped distribution, 1 standard deviation on either side of the mean contains 66% of the estimates • 2 standard deviations contain on either side of the mean contains 97% of the estimates • 1.96 standard deviations contain 95% of the estimates
  • 21. Sampling distribution showing effect of sampling error (SE). Sheldon T A Evid Based Nurs 2000;3:36-39 ©2000 by BMJ Publishing Group Ltd and RCN Publishing Company Ltd
  • 22. Calculate 95% confidence interval • Calculate sample statistic (point estimate) • Calculate “standard error” (SE) of the statistic – “Standard error” is similar to standard deviation (ie: standard deviation of the sample population) – Measure of the “spread” of the data – Affected by sample size • Calculate 1.96 x SE • Upper limit: Point estimate + 1.96xSE • Lower limit: Point estimate -1.96xSE
  • 23. Sample size • Larger sample size – smaller standard error – narrower confidence intervals • Greater precision • If the upper limit and lower limit include / cross the value 1, then the result is not statistically significant (at 5% level)
  • 24. The larger the sample (n), the smaller the sampling error. Sheldon T A Evid Based Nurs 2000;3:36-39 ©2000 by BMJ Publishing Group Ltd and RCN Publishing Company Ltd
  • 25. Reporting a confidence interval • “The truth” existed before you took your sample, it is what it is, and it is unchanging • Your estimates may be variable (depending on how you took the sample, how many times you repeat the test) • The truth is fixed, your estimates are flexible • “We can say with 95% confidence that this interval includes/covers/overlaps the Truth” • You cannot say: “The truth falls within this interval” – Implies that your borders are fixed, and the truth is variable, may “fall” here or “fall” there – The truth is fixed! Your intervals are variable
  • 26. Advantage of confidence intervals • Can see size of effect • Width of confidence interval gives idea of the “stability” of the estimate – Sample size? – Effect of some extreme outlier values? – Random error? • Narrow CI’s are always better!
  • 27. P Value vs CI • Hypothetical disease: • Which exposures are statistically significant? (p values) • Which has widest CI? (most affected by random error) • Which are most precise (most trustworthy, less likely to change with repeat testing)? Exposure Relative risk 95% CI P value A 2.1 0.6 – 7.8 0.24 B 1.6 1.3 – 2.0 0.001 C 4.4 1.5 – 12.4 0.002
  • 28. Past paper examples: Mar 2008 • You are interested in interventions that could be used in the area that could prevent relapse after discharge in children with severe malnutrition treated at the hospital. You find the following article during an evidence-base search • “Home based therapy for severe malnutrition with ready-to-use food “ – M J Manary, M J Ndkeha, P Ashorn, K Maleta, A Briend • Background: – The standard treatment of severe malnutrition in Malawi often utilises prolonged inpatient care, and after discharge results in high rates of relapse. • Aims: – To test the hypothesis that the recovery rate, defined as catch-up growth such that weight- for-height z score >0 (WHZ, based on initial height) for ready-to-use food (RTUF) is greater than two other home based dietary regimens in the treatment of malnutrition. • Methods: – HIV negative children >1 year old discharged from the nutrition unit in Blantyre, Malawi were randomised to one of three dietary regimens: RTUF, RTUF supplement, or blended maize/soy flour. RTUF and maize/soy flour provided 730 kJ/kg/day, while the RTUF supplement provided a fixed amount of energy, 2100 kJ/day. – Children were followed fortnightly. Children completed the study when they reached WHZ >0, relapsed, or died. – Outcomes were compared using a time-event model.
  • 29. • Results: – A total of 282 children were enrolled. – Children receiving RTUF were more likely to reach WHZ >0 than those receiving RTUF supplement or maize/soy flour (95% v 78%, RR 1.2, 95% CI 1.1 to 1.3). – Intention to treat analyses also showed that more children receiving RTUF reached graduation weight than those receiving RTUF supplement or maize/soy (86% v 66%, 20% difference, 95% CI 8% to 33%). – The average weight gain was 5.2 g/kg/day in the RTUF group compared to 3.1 g/kg/day for the maize/soy and RTUF supplement groups. Six months later, 96% of all children who reached graduation weight and returned for follow up, had normal anthropometric indices • Abbreviations: – MUAC, mid-upper arm circumference; NRU, nutritional rehabilitation unit; RTUF, ready-to-use food; WHZ, weight-for-height z score
  • 30. • a) What type of study design was used? (1) • b) What was the main study outcome? (1) • c) How would you interpret a weight-for-height z-score of 0 and -1? (2) • d) How would you interpret the relative risk of 1.2 in the statement “Children receiving RTUF were more likely to reach WHZ >0 than those receiving RTUF supplement or maize/soy flour (95% v 78%, RR 1.2, 95% CI 1.1 to 1.3).”? (1) • e) How would you interpret the 95% confidence interval of 1.1 to 1.3 in the same sentence? (1) • f) Was this difference statistically significant? Explain. (1) • g) What statistical test would you use to decide if the average weight gain in the RTUF group was significantly different to the maize/soy and RTUF supplement groups? (1) • h) What would your conclusion be about managing children with severe malnutrition at home, based on this Study? (3)
  • 33. Sept 2008: ex prem, spastic di